Western blot assay showed that the level of TGFβ1 was upregulated approximately four times in 11 liver cancer samples, whereas TGFβR1 expression remained moderate decrease (Fig. 6b; Supplementary Fig. 6a). The gene discussed is TGFBR1; the disease is liver cancer.